BeiGene UK Independently created content that was funded by BeiGene UK. The Pharmaceutical Journal retains editorial responsibility.

BeiGene UK

Independently created content that was funded by BeiGene UK. The Pharmaceutical Journal retains editorial responsibility.

How can pharmacists best support patients with chronic lymphocytic leukaemia?

As therapies for chronic lymphocytic leukaemia have evolved, so has pharmacists’ role in treating people with this type of blood cancer.…

Supported content

BTK inhibitors: what pharmacists need to know

In this episode of The PJ Pod, we consider the impact bruton tyrosine kinase (BTK) inhibitors have had on care for patients with B-cell malignancies and explore how pharmacists can help patients get the best out of their treatment regimens.…

Supported content